About PsiOxus

Sponsor retains sole responsibility for content.

PsiOxus aims to be the world’s leading cancer gene therapy company, delivering medicines of value to patients with cancer. We focus on discovering and developing innovative gene-based immuno-oncology treatments for solid tumors using our proprietary intravenously administered T-SIGn virus platform. Our portfolio of differentiated gene therapy products are all delivered systemically but act locall...

PsiOxus aims to be the world’s leading cancer gene therapy company, delivering medicines of value to patients with cancer. We focus on discovering and developing innovative gene-based immuno-oncology treatments for solid tumors using our proprietary intravenously administered T-SIGn virus platform. Our portfolio of differentiated gene therapy products are all delivered systemically but act locally within the tumor. At PsiOxus we are advancing our internal early and clinical stage candidates and establishing strategic partnerships with immuno-oncology leaders to bring our cancer gene therapy products to patients.

Contact PsiOxus

Phone Number
+44 (0) 1235 835 328

More About PsiOxus

Therapeutic Areas
  • Oncology
Technologies
  • Vaccines
Company Type
  • Biotechnology – Therapeutics
State of Ownership
  • Private
Sponsorship Group
  • Networker